Cadence Pharmaceuticals Income Statement
View: Annual | Quarterly
This data is provided as per license from EDGAR Online
| Dec 07 | Dec 06 | Dec 05 | |
|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 |
| Cost of Goods Sold | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| Gross Profit Margin | 0.0% | 0.0% | 0.0% |
| SG&A Expense | 53.6 | 53.4 | 7.7 |
| Depreciation & Amortization | 0.6 | 0.2 | 0.0 |
| Operating Income | (54.2) | (53.6) | (7.8) |
| Operating Margin | -- | -- | -- |
| Nonoperating Income | 3.4 | 1.9 | 0.3 |
| Nonoperating Expenses | 0.9 | 0.5 | -- |
| Income Before Taxes | (51.7) | (52.2) | (7.5) |
| Income Taxes | -- | -- | -- |
| Net Income After Taxes | (51.7) | (52.2) | (7.5) |
| Continuing Operations | (51.7) | (52.2) | (7.5) |
| Discontinued Operations | -- | -- | -- |
| Total Operations | (51.7) | (52.2) | (7.5) |
| Total Net Income | (51.7) | (52.2) | (7.5) |
| Net Profit Margin | -- | -- | -- |
| Diluted EPS from Total Net Income ($) | (1.81) | (10.07) | (1.63) |
| Dividends per Share | -- | -- | -- |
This data is provided as per license from EDGAR Online
